Kiyoshi Eshima
Oprichter bij DELTA-FLY PHARMA, INC.
Vermogen: 2 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Kiyoshi Eshima
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Unknown | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Kiyoshi Eshima via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
FUJI PHARMA CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
PERSEUS PROTEOMICS INC. | Pharmaceuticals: Major | Director/Board Member | |
TOWNNEWS-SHA CO.,LTD. | Publishing: Books/Magazines | Director/Board Member | |
Mizuho Securities Co., Ltd.
Mizuho Securities Co., Ltd. Investment Banks/BrokersFinance Mizuho Securities Co., Ltd. engages in the financial instruments business that includes sales and trade of equity and bond, research, and investment trusts. It operates through the following business divisions: Retail, Corporate Investment Services, and Markets and Products. The Retail business division markets equities, bonds, investment trusts, and insurance for individual clients. The Corporate Investment Services business division offers securities solutions, investment banking, management strategies and raising funds for corporate clients. The Markets and Products division handles the product development. The company was founded in July 1917 and is headquartered in Tokyo, Japan. | Investment Banks/Brokers | Corporate Officer/Principal | |
Bristol-Myers Squibb KK
Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The company is based in Shinjuku-ku, Japan. | Biotechnology | Corporate Officer/Principal | |
VERITAS IN SILICO INC. | Biotechnology | Director/Board Member | |
Awa Kyoudou Law Office | Corporate Officer/Principal | ||
LBA Advisory Co., Ltd. | Director/Board Member | ||
LBA Tax Accountant Corp. | Corporate Officer/Principal | ||
Tech & FinStrategy, Inc.
Tech & FinStrategy, Inc. Miscellaneous Commercial ServicesCommercial Services Tech & FinStrategy, Inc. provides business consulting and plan preparation support services. The private company is based in Tokyo, Japan. | Miscellaneous Commercial Services | President | |
IMK Life Science KK | President | ||
Myanmar Bridge Corp. | Director/Board Member | ||
Sachio Kishii C.P.A. office | Director/Board Member |
Statistieken
Internationaal
Japan | 15 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Finance | 2 |
Commercial Services | 2 |
Operationeel
Director/Board Member | 15 |
Corporate Officer/Principal | 9 |
Independent Dir/Board Member | 6 |
Chief Administrative Officer | 3 |
Investor Relations Contact | 2 |
Sterkste connecties
- Beurs
- Insiders
- Kiyoshi Eshima
- Bedrijfsconnecties